A Case of Drug-Induced Lupus in Crohn’s Disease During Infliximab Therapy

A 46-year-old man with a known case of Crohn's disease, which developed in August 2010, had been in remission since then with infliximab treatment. However, in November 2023, he developed photosensitivity, followed by joint pain and general fatigue in December. Blood tests revealed positive antinuclear antibodies, leading to a diagnosis of drug-induced lupus. After switching from infliximab to vedolizumab, his symptoms improved, and antinuclear antibodies became negative. We present a case of Crohn's disease in which drug-induced lupus developed after approximately 14 years of infliximab treatment. Cases of drug-induced lupus developing from long-term administration of tumor necrosis factor alpha (TNFα) inhibitors are rare, so we report this case with a literature review.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-11-29
DOI
https://doi.org/10.7759/cureus.74782
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Drug-Induced Lupus in Crohn’s Disease During Infliximab Therapy

Tomotaka Tanaka, Keiko Arataki, Syohei Ishimaru, Daiki Hirano
Cureus
Systemic Lupus Erythematosus Research
article

A Case of Drug-Induced Lupus in Crohn’s Disease During Infliximab Therapy

Tomotaka Tanaka, Keiko Arataki, Syohei Ishimaru, Daiki Hirano
article en

Abstract

A 46-year-old man with a known case of Crohn's disease, which developed in August 2010, had been in remission since then with infliximab treatment. However, in November 2023, he developed photosensitivity, followed by joint pain and general fatigue in December. Blood tests revealed positive antinuclear antibodies, leading to a diagnosis of drug-induced lupus. After switching from infliximab to vedolizumab, his symptoms improved, and antinuclear antibodies became negative. We present a case of Crohn's disease in which drug-induced lupus developed after approximately 14 years of infliximab treatment. Cases of drug-induced lupus developing from long-term administration of tumor necrosis factor alpha (TNFα) inhibitors are rare, so we report this case with a literature review.

CureusVol. 16(11)
Hiroshima General Hospital (JP)
Good health and well-being
Openalex Percentile: Top 62%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.